On November 2, 2022, Aimed Alliance hosted a legislative briefing on facilitating access to medications for opioid use disorders (“MOUD”). Aimed Alliance is a non-profit health policy organization that seeks to protect and enhance the rights of healthcare consumers and providers. The objective of this legislative briefing was to educate patient and professional advocacy groups on the current state of drug poisoning in the United States, and the need for the United States Senate to pass S.3257 to expand the “14-day limit” to 60-days to ensure patients with opioid use disorder (OUD) can access their treatments. To learn more about the urgent need to expand access to MOUD, read the Executive Summary here.
If you would like to support the passage of S.3257 please review our fact sheets to determine how you can best show the Senate your support:
Fact Sheet for Advocates: S.3257 Reducing Barriers to MOUD
Fact Sheet for Senators and Senate Staff: Senators Pass S.3257 To Facilitate Access to MOUD
Last Updated on November 16, 2022 by Aimed Alliance
